Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Laura C. Coates, Arthur Kavanaugh, Philip J. Mease, Enrique R. Soriano, Maria Laura Acosta-Felquer, April W. Armstrong, Wilson Bautista-Molano, Wolf Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R. Espinoza, Oliver Fitzgerald, Dafna D. Gladman, Alice Gottlieb, Philip S. Helliwell, M. Elaine Husni, Thorvardur J. Love, Ennio Lubrano, Neil Mchugh, Peter Nash & 10 others Alexis Ogdie, Ana-Maria Orbai, Andrew Parkinson, Denis O'Sullivan, Cheryl F. Rosen, Sergio Schwartzman, Evan L. Siegel, Sergio Toloza, William Tuong, Christopher T. Ritchlin

Research output: Contribution to journalArticle

Abstract

Objective: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). Methods: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA, based on consensus achieved at face-to-face meetings and via online surveys. We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, using an online questionnaire. Results: Six overarching principles had ≥80% agreement among both health care professionals (n=135) and patient research partners (n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin disease, nail disease, and comorbidities in the setting of PsA, using the Grading of Recommendations, Assessment, Development and Evaluation process. Agreement of >80% was reached for approval of the individual recommendations and the overall schema. Conclusion: We present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other health care providers, and patient research partners). Further updates are anticipated as the therapeutic landscape in PsA evolves.

Original languageEnglish (US)
JournalArthritis and Rheumatology
DOIs
StateAccepted/In press - 2016

Fingerprint

Psoriatic Arthritis
Psoriasis
Research
Nail Diseases
Therapeutics
Spondylitis
Comorbidity
Skin Diseases
Arthritis
Health Personnel

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology

Cite this

Coates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta-Felquer, M., Armstrong, A. W., ... Ritchlin, C. T. (Accepted/In press). Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis and Rheumatology. https://doi.org/10.1002/art.39573

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. / Coates, Laura C.; Kavanaugh, Arthur; Mease, Philip J.; Soriano, Enrique R.; Laura Acosta-Felquer, Maria; Armstrong, April W.; Bautista-Molano, Wilson; Boehncke, Wolf Henning; Campbell, Willemina; Cauli, Alberto; Espinoza, Luis R.; Fitzgerald, Oliver; Gladman, Dafna D.; Gottlieb, Alice; Helliwell, Philip S.; Husni, M. Elaine; Love, Thorvardur J.; Lubrano, Ennio; Mchugh, Neil; Nash, Peter; Ogdie, Alexis; Orbai, Ana-Maria; Parkinson, Andrew; O'Sullivan, Denis; Rosen, Cheryl F.; Schwartzman, Sergio; Siegel, Evan L.; Toloza, Sergio; Tuong, William; Ritchlin, Christopher T.

In: Arthritis and Rheumatology, 2016.

Research output: Contribution to journalArticle

Coates, LC, Kavanaugh, A, Mease, PJ, Soriano, ER, Laura Acosta-Felquer, M, Armstrong, AW, Bautista-Molano, W, Boehncke, WH, Campbell, W, Cauli, A, Espinoza, LR, Fitzgerald, O, Gladman, DD, Gottlieb, A, Helliwell, PS, Husni, ME, Love, TJ, Lubrano, E, Mchugh, N, Nash, P, Ogdie, A, Orbai, A-M, Parkinson, A, O'Sullivan, D, Rosen, CF, Schwartzman, S, Siegel, EL, Toloza, S, Tuong, W & Ritchlin, CT 2016, 'Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis', Arthritis and Rheumatology. https://doi.org/10.1002/art.39573
Coates, Laura C. ; Kavanaugh, Arthur ; Mease, Philip J. ; Soriano, Enrique R. ; Laura Acosta-Felquer, Maria ; Armstrong, April W. ; Bautista-Molano, Wilson ; Boehncke, Wolf Henning ; Campbell, Willemina ; Cauli, Alberto ; Espinoza, Luis R. ; Fitzgerald, Oliver ; Gladman, Dafna D. ; Gottlieb, Alice ; Helliwell, Philip S. ; Husni, M. Elaine ; Love, Thorvardur J. ; Lubrano, Ennio ; Mchugh, Neil ; Nash, Peter ; Ogdie, Alexis ; Orbai, Ana-Maria ; Parkinson, Andrew ; O'Sullivan, Denis ; Rosen, Cheryl F. ; Schwartzman, Sergio ; Siegel, Evan L. ; Toloza, Sergio ; Tuong, William ; Ritchlin, Christopher T. / Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. In: Arthritis and Rheumatology. 2016.
@article{c8a73558aaee4ecb86b152f260346b89,
title = "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis",
abstract = "Objective: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). Methods: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA, based on consensus achieved at face-to-face meetings and via online surveys. We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, using an online questionnaire. Results: Six overarching principles had ≥80{\%} agreement among both health care professionals (n=135) and patient research partners (n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin disease, nail disease, and comorbidities in the setting of PsA, using the Grading of Recommendations, Assessment, Development and Evaluation process. Agreement of >80{\%} was reached for approval of the individual recommendations and the overall schema. Conclusion: We present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other health care providers, and patient research partners). Further updates are anticipated as the therapeutic landscape in PsA evolves.",
author = "Coates, {Laura C.} and Arthur Kavanaugh and Mease, {Philip J.} and Soriano, {Enrique R.} and {Laura Acosta-Felquer}, Maria and Armstrong, {April W.} and Wilson Bautista-Molano and Boehncke, {Wolf Henning} and Willemina Campbell and Alberto Cauli and Espinoza, {Luis R.} and Oliver Fitzgerald and Gladman, {Dafna D.} and Alice Gottlieb and Helliwell, {Philip S.} and Husni, {M. Elaine} and Love, {Thorvardur J.} and Ennio Lubrano and Neil Mchugh and Peter Nash and Alexis Ogdie and Ana-Maria Orbai and Andrew Parkinson and Denis O'Sullivan and Rosen, {Cheryl F.} and Sergio Schwartzman and Siegel, {Evan L.} and Sergio Toloza and William Tuong and Ritchlin, {Christopher T.}",
year = "2016",
doi = "10.1002/art.39573",
language = "English (US)",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

AU - Coates, Laura C.

AU - Kavanaugh, Arthur

AU - Mease, Philip J.

AU - Soriano, Enrique R.

AU - Laura Acosta-Felquer, Maria

AU - Armstrong, April W.

AU - Bautista-Molano, Wilson

AU - Boehncke, Wolf Henning

AU - Campbell, Willemina

AU - Cauli, Alberto

AU - Espinoza, Luis R.

AU - Fitzgerald, Oliver

AU - Gladman, Dafna D.

AU - Gottlieb, Alice

AU - Helliwell, Philip S.

AU - Husni, M. Elaine

AU - Love, Thorvardur J.

AU - Lubrano, Ennio

AU - Mchugh, Neil

AU - Nash, Peter

AU - Ogdie, Alexis

AU - Orbai, Ana-Maria

AU - Parkinson, Andrew

AU - O'Sullivan, Denis

AU - Rosen, Cheryl F.

AU - Schwartzman, Sergio

AU - Siegel, Evan L.

AU - Toloza, Sergio

AU - Tuong, William

AU - Ritchlin, Christopher T.

PY - 2016

Y1 - 2016

N2 - Objective: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). Methods: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA, based on consensus achieved at face-to-face meetings and via online surveys. We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, using an online questionnaire. Results: Six overarching principles had ≥80% agreement among both health care professionals (n=135) and patient research partners (n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin disease, nail disease, and comorbidities in the setting of PsA, using the Grading of Recommendations, Assessment, Development and Evaluation process. Agreement of >80% was reached for approval of the individual recommendations and the overall schema. Conclusion: We present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other health care providers, and patient research partners). Further updates are anticipated as the therapeutic landscape in PsA evolves.

AB - Objective: To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting patients with psoriatic arthritis (PsA). Methods: GRAPPA rheumatologists, dermatologists, and PsA patients drafted overarching principles for the management of PsA, based on consensus achieved at face-to-face meetings and via online surveys. We conducted literature reviews regarding treatment for the key domains of PsA (arthritis, spondylitis, enthesitis, dactylitis, skin disease, and nail disease) and convened a new group to identify pertinent comorbidities and their effect on treatment. Finally, we drafted treatment recommendations for each of the clinical manifestations and assessed the level of agreement for the overarching principles and treatment recommendations among GRAPPA members, using an online questionnaire. Results: Six overarching principles had ≥80% agreement among both health care professionals (n=135) and patient research partners (n=10). We developed treatment recommendations and a schema incorporating these principles for arthritis, spondylitis, enthesitis, dactylitis, skin disease, nail disease, and comorbidities in the setting of PsA, using the Grading of Recommendations, Assessment, Development and Evaluation process. Agreement of >80% was reached for approval of the individual recommendations and the overall schema. Conclusion: We present overarching principles and updated treatment recommendations for the key manifestations of PsA, including related comorbidities, based on a literature review and consensus of GRAPPA members (rheumatologists, dermatologists, other health care providers, and patient research partners). Further updates are anticipated as the therapeutic landscape in PsA evolves.

UR - http://www.scopus.com/inward/record.url?scp=84959912573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959912573&partnerID=8YFLogxK

U2 - 10.1002/art.39573

DO - 10.1002/art.39573

M3 - Article

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

ER -